Variant report
Variant | esv3391073 |
---|---|
Chromosome Location | chr4:144176349-144176871 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:144175749..144177348-chr4:144177529..144179744,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs571127476 | chr4:144176350-144176351 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs374056857 | chr4:144176394-144176395 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs62330315 | chr4:144176410-144176411 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs373301348 | chr4:144176413-144176414 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs534967463 | chr4:144176414-144176415 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs375959090 | chr4:144176415-144176416 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs141654795 | chr4:144176418-144176419 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs5862627 | chr4:144176422-144176423 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs56057243 | chr4:144176428-144176429 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs28441426 | chr4:144176429-144176430 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs28634281 | chr4:144176430-144176431 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs145318259 | chr4:144176475-144176476 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs367935162 | chr4:144176487-144176488 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs568435739 | chr4:144176493-144176494 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs35887480 | chr4:144176497-144176498 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs183951274 | chr4:144176505-144176506 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs2010767 | chr4:144176546-144176547 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs188728994 | chr4:144176554-144176555 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs557619026 | chr4:144176569-144176570 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs367796536 | chr4:144176609-144176610 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs79356643 | chr4:144176657-144176658 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs191690005 | chr4:144176687-144176688 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs561376115 | chr4:144176694-144176695 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs573288849 | chr4:144176715-144176716 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs543946270 | chr4:144176720-144176721 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs184143947 | chr4:144176721-144176722 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs532842193 | chr4:144176733-144176734 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs11932889 | chr4:144176770-144176771 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs369341485 | chr4:144176777-144176778 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs533955907 | chr4:144176778-144176779 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs35411225 | chr4:144176835-144176836 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Mental retardation | 17901693 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Breast cancer | 22048815 | CNVD |
Autism | 22241247 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:144172800-144179800 | Weak transcription | H9 Cell Line | embryonic stem cell |
2 | chr4:144172800-144184000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
3 | chr4:144173600-144184000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
4 | chr4:144174400-144177600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr4:144174800-144177600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr4:144174800-144177600 | Weak transcription | HMEC | breast |
7 | chr4:144174800-144177600 | Weak transcription | NHEK | skin |
8 | chr4:144175800-144176400 | Enhancers | Hela-S3 | cervix |
9 | chr4:144175800-144176600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
10 | chr4:144176000-144177800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr4:144176200-144176600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr4:144176400-144177800 | Weak transcription | Hela-S3 | cervix |